H-1B sponsorship profile: Cerevel Therapeutics, LLC. Across U.S. Department of Labor LCA disclosures, Cerevel Therapeutics, LLC filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (7 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Cerevel Therapeutics, LLC’s H-1B petitions range from $120,119 at the low end to $300,000 at the high end, with a petition-weighted average of $162,874. That range reflects the mix of occupations the company sponsors, led by Principal Analyst, Clinical Programming (2 petitions at $139,500 avg), followed by Senior Manager, Clinical Pharmacology and Senior Director, Medical Affairs. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Cerevel Therapeutics, LLC is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 2 states, most heavily in MA, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Cerevel Therapeutics, LLC ranks. By H-1B petition volume, Cerevel Therapeutics, LLC is #21,197 of 119,880 employers nationally and #921 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.